Albert Bourla· @AlbertBourla · X·· 2026-06-26AI 评分42
AI 导读
我们在VESPER-6中完成了首例受试者给药，这是我们在研肥胖领域领先候选药物的最新一项III期试验，并启动了一项IIb期研究，测试其与一种在研胰淀素类似物的联合用药。
正文
We dosed the first participants in VESPER-6, the latest Phase 3 trial of our lead investigational medicine in obesity and started a Phase 2b study testing it in combination with an investigational amylin analog.
来源：Albert Bourla · x.com